A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

You are reading our weekly Well+Being newsletter. Sign up here to get it delivered to your inbox every Thursday. Happy ...

"Inside the NBA" featured some more cracks between colleagues on Tuesday night, as Shaquille O'Neal called for the "Ozempic ...

There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

The Biden administration proposed a rule for Medicare and Medicaid to cover the costs of weight-loss drugs for millions of ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of nearly 600 ...

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...